Cancer Diagnostics & Trials: LabPMM® (Invivoscribe) rolled out global KMT2A MRD testing via digital PCR, aiming to track deep molecular response in acute leukemia as menin inhibitors move into frontline and combination studies. Oncology Innovation: Nature reported a surge in bispecific antibodies moving from lab to clinic, with researchers now pushing multispecific designs to better tackle tumor resistance. Health Policy & Access: China’s State Council said city governments must provide basic public services—education, housing, social security, and medical care—to permanent residents regardless of hukou registration, a major shift for migrants and graduates. Wellness Trend Watch: Chinese youth are turning to TCM “qushi” (eliminating dampness) for fatigue and oily skin, driving demand for cupping, herbal foot baths, and related remedies. Public Health Systems: A Malawi tobacco-cessation analysis highlights gaps in structured services, limited nicotine replacement availability, and reliance on brief frontline advice. Medical Tourism Signal: South Korea saw a rebound in Chinese visitors and rapid growth in medical tourism, boosting foreign spending in the first half. Market/Industry Context: AstraZeneca’s reported merger talks with Bristol Myers Squibb could reshape pharma scale, with China manufacturing investment noted as part of its growth push.